Latest News
Orchestra BioMed Holdings, Inc.
- Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
- Orchestra BioMed to host R&D Day on Nov 12 show...
- Orchestra BioMed to Host R&D Day Featuring Clinical
- Orchestra BioMed (OBIO) Falls 5.05% to $5.45 as Shares Retreat Toward Lower Support - Put Spread Alert
- Orchestra BioMed (OBIO) Falls 5.05% to $5.45 as Shares Retreat Toward Lower Support - GEX Level
- Orchestra (OBIO) Leaps +1.86% as Positive Sentiment Builds 2026-10-15 - High Conviction Picks
- Piper Sandler reiterates Orchestra BioMed stock rating on AVIM trial By Investing.com
- Orchestra BioMed Has A Clearer Trial Timeline But A Demanding Valuation
- H.C. Wainwright reiterates Orchestra BioMed stock rating on trial enrollment By Investing.com
- Orchestra Biomed - Primary Endpoint Data to B
- Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
- Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
Headlines from the last 30 days, linking to the original publishers. See all market news →